Oncology leaders separate hype from reality on AI's evolving role in cancer care today. This panel examines where AI is already improving scheduling, documentation, and diagnostics, where clinical limitations remain, and what governance, training, and infrastructure investments are needed before broader adoption can safely expand across oncology programs nationwide.